£495k
+90%vs Mar 2024Active09733813Private limited companyHorsham
GLOBAL EYE TRIALS LTD
Significant control: Balbir Singh Sewak (25–50%), Ria Ramesh Patel (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Global Eye Trials Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
GLOBAL EYE TRIALS LTD is an active private limited company (company number 09733813) incorporated on 14 August 2015, registered in Horsham. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 March 2025, showing net assets of £495k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 90% on the prior period (£260k).
Peer position · net assets
By net assets it sits in the top quarter of 54 comparable companies in Surrey (median £1,000, upper quartile £121k).
02
Ownership and control
- Mr Balbir Singh Sewak
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Ms Ria Ramesh Patel
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Harbinder Kaur Bhogal
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 14 August 201511 yrs ago
- Next accounts due
- 31 December 2026in 68 days
- Confirmation statement due
- 28 August 2027in 308 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
2
No changevs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £495k | — | — | — | — | — | 2 |
| 31 March 2024 | £260k | — | — | — | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £494,558 at 31 March 2025
- Net assets up 10% or more on the prior period+90.1% vs prior period
- Incorporated five or more years agoIncorporated 14 August 2015
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 308 days
- Next accounts duein 68 days
- Accounts period endNet assets £495k · micro accounts
- Accounts period endNet assets £260k · micro accounts
- Incorporated
08
Similar companies in Surrey
- CREDOS CONSULTING LIMITEDHaywards Heath · inc. Sept 2015
- HEATH RESEARCH LTDFarnham · inc. Jun 2015
- LIMEWAY PHARMA DESIGN LIMITEDDorking · inc. Mar 2015
- MEDSA DEVELOPMENT LTDFarnham · inc. Feb 2016
- TRUSPINE TECHNOLOGIES INTERNATIONAL LIMITEDGatwick · inc. Dec 2014
- TSP ADVANCED TECHNOLOGIES PLCGatwick · inc. Dec 2014
All companies incorporated on 14 August 2015 · in Aug 2015.
09
Reminders for GLOBAL EYE TRIALS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.